Whether it’s $100k in revenue or another relative inflection point, make sure your cofounders can get there without hiring any external talent. We brought on Caya (CEO of Slidebean) to provide a smart framework on how to find the right cofounders that can hit this mark.

Most founders consider two possibilities when thinking about their exit strategy: IPO or acquisition. The process of startup M&A likely remains shrouded in mystery for founders who have never seen it first-hand. We invited Amit Yoran, CEO of Tenable, and Mike Viscuso, Co-Founder of Carbon Black, on #DreamitLive to answer these questions and more. We pulled out 5 key lessons from the discussion to shed some light on M&A and help you navigate what can either be an extremely rewarding or painful process.

Traction is one of the most important elements to nail when pitching investors. The problem is, most startups do a poor job talking about it. In this Dreamit Dose, Managing Partner Steve Barsh highlights pro tips and traction insights across all early stages of the startup lifecycle. From pre-revenue early traction to post-revenue momentum, this Dose will teach you the ins and outs of presenting traction to investors.

Uncertainty and startups go hand in hand. Whether you’re planning micro-pivots to product development or macro-pivots in light of recent market change, you’ll need a well-tuned internal schema to assess uncertainty. In the wake of the pandemic, startups across all stages have been pressed to make swift decisions and adjust plans. Today, more than ever, the relevant question founders should be asking themselves is: what’s my bet?

Speaking to investors can require a language of its own. Word choice is important and even the smallest detail can make or break your startup pitch. Adam Dakin, Managing Director of Dreamit Healthtech, sees founders make the same common pitch mistakes over and over. Luckily, he’s a pro when it comes to pitching investors and distills the advice so it’s easy to avoid. In this Dreamit Dose, Adam dives into the language of the pitch and flags three common mistakes you’ll want to avoid.

Today, Infermedica (HT ‘18) announced a $10M Series A financing round for their AI-driven platform that helps insurance, telemedicine companies, and health systems increase efficiency through fast, digital symptom-checks. The platform has nearly 60 B2B partners across 30 countries, including Microsoft, Allianz, Global Excel, Sana Kliniken, and Médis, and has performed more than 6 million health checks globally. Read here.

TrekIT Health (HT- ‘18) announced closing $1M in additional seed financing. TrekIt’s technology is a HIPAA compliant and secure, real-time workspace for synthesizing information across EHRs and care teams. Clinicians love TrekIT because of its intuitive and predictive interface which serves as a cure for disjointed information systems and a replacement for paper task lists. Read more.

To keep an organization safe, a CISO depends on as many as 50 to 100 different products. This presents a huge opportunity for startups. However, this means that a CISO sees a LOT of pitches in their role. In this Dreamit Dose, Mel tells you the five ways to get a CISO to buy your product.

When you’re raising a bridge round and pitching investors, their first reaction may be that you’re in trouble. To overcome this, you’ll need to understand how to frame your bridge round ask, overcome assumptions investors often make, and how to structure startup bridge round pitches.

Ruvna, a safety and communication platform for school systems, is releasing a new product this fall providing COVID-19 screening, tracking, and compliance for schools and districts called Ruvna Health. Learn more about the solution here.

Last week, EnsoData (Healthtech - Spring 2019) announced a $9 million Series A financing round led by Venture Investors and Zetta Venture Partners, with participation from Dreamit Ventures. Their platform transforms billions of waveform data points collected from sensors in medical devices and wearables into an easy-to-read report, so clinicians can make faster, more accurate diagnoses.

Good founders know the importance of nailing their product demo. While many demo, few excel at it. In this #DreamitDose, Managing Partner Steve Barsh gives founders a simple framework to crush your demo. Along the way, Steve reveals pro tips like how to layer in traction and provides an example of a truly compelling use case.

Wellth, a platform designed to improve treatment adherence using behavioral economics, announced the closing of their $10M Series A round, co-led by yabeo and Boehringer Ingelheim Venture Fund (BIVF). Wellth graduated from Dreamit’s Healthtech program in 2016.

Amongst the many stresses of COVID-19, some of the greatest challenges for founders have not been profit-focused, but people-focused. Learn more about encouraging employee wellbeing and how to manage your workforce during this time.

Net Health has acquired Tissue Analytics, a pioneering developer of automated mobile wound and skin imaging and predictive analytics solutions. The Baltimore-based startup graduated from Dreamit’s Healthtech program in 2014.

Will the pandemic change healthcare? Earlier this month, Adam Dakin, Managing Director of Dreamit Healthtech, joined Phase2 Health to share his insight on the topic. Read to explore shifts in venture investment, healthtech trends, and what the world will look like after Covid-19.

Use this formula to determine the appropriate amount of funding for your investor ask. This framework helps founders position their fundraising targets and avoid red flags with investors.

Before you can deliver a bulls*** free pitch, you must know what red flags to avoid. There are several instant indicators that will immediately cause you to lose credibility with investors and prospective customers. We go over them and tell you how to avoid them here.

Bullpen Capital General Partner Paul Martino on the state of the VC ecosystem in the current economic crisis, the two types of crisis we might be facing over the coming months, the ways that VC deal terms and investment activity might change during the slowdown, and more.

Jason Calacanis (@jason), angel investor in many category-defining companies, including, Uber, Thumbtack, Wealthfront, Robinhood, and Calm, says you absolutely should. Jason sat down with Steve Barsh, Managing Partner of Dreamit, to give founders relevant downturn strategies and provide advice on what founders should focus on if they’re considering raising at this time.